Loading...

Shauna Farr-Jones, PhD

Title(s)Academic Coordinator III, Anesthesia
SchoolSchool of Medicine
Address1001 Potrero Ave
San Francisco CA 94110
Phone415-754-8091
ORCID ORCID Icon0000-0003-4130-6332 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Tufts University, Boston, MAPh.D.06/1989Biochemistry
    University of Southampton, Southampton, UKBSc(Hons)6/1980Chemistry

    Collapse Research 
    Collapse Research Activities and Funding
    Antibody Technology Reseach Center
    NIH/NCI P41CA196276Sep 24, 2014 - Aug 31, 2019
    Role: Co-Investigator
    Role Description: Project Manager
    BROAD SPECTRUM MONOCLONAL ANTIBODY-BASED THERAPEUTIC FOR BOTULISM
    NIH 272201100031C-4-0-1Sep 30, 2011 - Sep 30, 2016
    Role: Co-Investigator
    BROAD SPECTRUM MONOCLONAL ANTIBODY-BASED THERAPEUTIC FOR BOTULISM
    NIH 272201100031C-1-0-1Sep 27, 2011 - Aug 1, 2015
    Role: Co-Investigator
    BROAD SPECTRUM MONOCLONAL ANTIBODY-BASED THERAPEUTIC FOR BOTULISM
    NIH 272201100031C-0-0-1Sep 27, 2011 - Sep 29, 2014
    Role: Co-Investigator
    Resource for Biocomputing, Visualization, and Informatics
    NIH/NCRR P41RR001081Jun 1, 1976 - Sep 14, 2012
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Featured Publications
    Collapse Faculty Mentoring
    Collapse Featured Presentations

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Antibody-Drug Conjugates Targeting the Urokinase Receptor (uPAR) as a Possible Treatment of Aggressive Breast Cancer. Antibodies (Basel). 2019 Nov 05; 8(4). Harel ET, Drake PM, Barfield RM, Lui I, Farr-Jones S, Van't Veer L, Gartner ZJ, Green EM, Lourenço AL, Cheng Y, Hann BC, Rabuka D, Craik CS. PMID: 31694242.
      View in: PubMed   Mentions:
    2. Pharmacokinetics of Human Recombinant Anti-Botulinum Toxin Antibodies in Rats. Toxins (Basel). 2019 06 17; 11(6). Espinoza Y, Wong D, Ahene A, Der K, Martinez Z, Pham J, Cobb RR, Farr-Jones S, Marks JD, Tomic MT. PMID: 31212950.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    3. Monoclonal Antibody Combinations Prevent Serotype A and Serotype B Inhalational Botulism in a Guinea Pig Model. Toxins (Basel). 2019 04 06; 11(4). Tomic MT, Espinoza Y, Martinez Z, Pham K, Cobb RR, Snow DM, Earnhart CG, Pals T, Syar ES, Niemuth N, Kobs DJ, Farr-Jones S, Marks JD. PMID: 30959899.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    4. An ambient temperature-stable antitoxin of nine co-formulated antibodies for botulism caused by serotypes A, B and E. PLoS One. 2018; 13(5):e0197011. Li M, Lee D, Obi CR, Freeberg JK, Farr-Jones S, Tomic MT. PMID: 29746518.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    5. Antibody engineering to improve manufacturability. Protein Expr Purif. 2018 09; 149:75-83. Wijesuriya SD, Pongo E, Tomic M, Zhang F, Garcia-Rodriquez C, Conrad F, Farr-Jones S, Marks JD, Horwitz AH. PMID: 29655788.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    6. A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes. Toxins (Basel). 2018 03 01; 10(3). Garcia-Rodriguez C, Razai A, Geren IN, Lou J, Conrad F, Wen WH, Farr-Jones S, Smith TJ, Brown JL, Skerry JC, Smith LA, Marks JD. PMID: 29494481.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    7. A Single Tri-Epitopic Antibody Virtually Recapitulates the Potency of a Combination of Three Monoclonal Antibodies in Neutralization of Botulinum Neurotoxin Serotype A. Toxins (Basel). 2018 02 15; 10(2). Lou J, Wen W, Conrad F, Meng Q, Dong J, Sun Z, Garcia-Rodriguez C, Farr-Jones S, Cheng LW, Henderson TD, Brown JL, Smith TJ, Smith LA, Cormier A, Marks JD. PMID: 29462889.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    8. Discovery of internalizing antibodies to basal breast cancer cells. Protein Eng Des Sel. 2018 01 01; 31(1):17-28. Zhou Y, Zou H, Yau C, Zhao L, Hall SC, Drummond DC, Farr-Jones S, Park JW, Benz CC, Marks JD. PMID: 29301020.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    9. High-throughput screening: update on practices and success. J Biomol Screen. 2006 Oct; 11(7):864-9. Fox S, Farr-Jones S, Sopchak L, Boggs A, Nicely HW, Khoury R, Biros M. PMID: 16973922.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    10. High-throughput screening: searching for higher productivity. J Biomol Screen. 2004 Jun; 9(4):354-8. Fox S, Farr-Jones S, Sopchak L, Boggs A, Comley J. PMID: 15191652.
      View in: PubMed   Mentions: 7     Fields:    
    11. High throughput screening 2002: moving toward increased success rates. J Biomol Screen. 2002 Aug; 7(4):313-6. Fox S, Wang H, Sopchak L, Farr-Jones S. PMID: 12230884.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Business and science of proteomics--third annual event. Next-generation technologies for high-throughput proteomics. IDrugs. 2001 Nov; 4(11):1235-6. Farr-Jones S. PMID: 15942822.
      View in: PubMed   Mentions:    Fields:    
    13. The Internet for nuclear magnetic resonance spectroscopists. Methods Enzymol. 2001; 338:247-57. Avizonis D, Farr-Jones S. PMID: 11460551.
      View in: PubMed   Mentions:    Fields:    
    14. Chemokine antagonists as anti-inflammatory and antiviral agents II. IDrugs. 2000 Jun; 3(6):584-5. Farr-Jones S. PMID: 16096911.
      View in: PubMed   Mentions:    Fields:    
    15. Solution structure of Syrian hamster prion protein rPrP(90-231). Biochemistry. 1999 Apr 27; 38(17):5362-77. Liu H, Farr-Jones S, Ulyanov NB, Llinas M, Marqusee S, Groth D, Cohen FE, Prusiner SB, James TL. PMID: 10220323.
      View in: PubMed   Mentions: 58     Fields:    Translation:AnimalsCells
    16. High Throughput Screening for Drug Discovery: Continually Transitioning into New Technology. J Biomol Screen. 1999; 4(4):183-186. Fox S, Farr-Jones S, Yund MA. PMID: 10838437.
      View in: PubMed   Mentions: 6     Fields:    
    17. NMR determination of the major solution conformation of a peptoid pentamer with chiral side chains. Proc Natl Acad Sci U S A. 1998 Apr 14; 95(8):4309-14. Armand P, Kirshenbaum K, Goldsmith RA, Farr-Jones S, Barron AE, Truong KT, Dill KA, Mierke DF, Cohen FE, Zuckermann RN, Bradley EK. PMID: 9539733.
      View in: PubMed   Mentions: 40     Fields:    Translation:Cells
    18. Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc Natl Acad Sci U S A. 1997 Sep 16; 94(19):10086-91. James TL, Liu H, Ulyanov NB, Farr-Jones S, Zhang H, Donne DG, Kaneko K, Groth D, Mehlhorn I, Prusiner SB, Cohen FE. PMID: 9294167.
      View in: PubMed   Mentions: 122     Fields:    Translation:HumansAnimalsCells
    19. Solution structure of omega-conotoxin MVIIC, a high affinity ligand of P-type calcium channels, using 1H NMR spectroscopy and complete relaxation matrix analysis. J Mol Biol. 1995 Apr 21; 248(1):106-24. Farr-Jones S, Miljanich GP, Nadasdi L, Ramachandran J, Basus VJ. PMID: 7731037.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    20. Converting trypsin to chymotrypsin: ground-state binding does not determine substrate specificity. Biochemistry. 1994 Jul 26; 33(29):8764-9. Hedstrom L, Farr-Jones S, Kettner CA, Rutter WJ. PMID: 8038166.
      View in: PubMed   Mentions: 11     Fields:    Translation:Cells
    21. Crystal versus solution structure of enzymes: NMR spectroscopy of a peptide boronic acid-serine protease complex in the crystalline state. Proc Natl Acad Sci U S A. 1989 Sep; 86(18):6922-4. Farr-Jones S, Smith SO, Kettner CA, Griffin RG, Bachovchin WW. PMID: 2780549.
      View in: PubMed   Mentions: 6     Fields:    Translation:Cells
    22. Crystal versus solution structures of enzymes: NMR spectroscopy of a crystalline serine protease. Science. 1989 May 26; 244(4907):961-4. Smith SO, Farr-Jones S, Griffin RG, Bachovchin WW. PMID: 2499045.
      View in: PubMed   Mentions: 10     Fields:    Translation:Cells
    23. Nitrogen-15 NMR spectroscopy of the catalytic-triad histidine of a serine protease in peptide boronic acid inhibitor complexes. Biochemistry. 1988 Oct 04; 27(20):7689-97. Bachovchin WW, Wong WY, Farr-Jones S, Shenvi AB, Kettner CA. PMID: 3207700.
      View in: PubMed   Mentions: 18     Fields:    Translation:Cells
    Shauna's Networks
    Concepts (120)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (11)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑